Moderna Inc. (NASDAQ:MRNA) is navigating challenges as its Covid vaccine business declines. Moderna Inc. (NASDAQ:MRNA)’s second commercially available product, RSV vaccines for seniors ...
Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a handful of its pipeline programs and terminate a few others. Now, management is ...
In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other Jim Cramer's best stocks for investors. In a recent episode of Mad Money, Jim Cramer ...
2 variant of the virus. The U.S. Food and Drug Administration has also approved the shot, as well as updated vaccines from Pfizer and BioNTech. Moderna (MRNA) shares surged Tuesday after ...